Filter announcements
Loading...
Alkem Laboratories is engaged in pharmaceutical business with global operations. The Company is engaged in the development, manufacture and sale of pharmaceutical and nutraceutical products.(Source : 202003-01 Annual Report Page No:107)
Alkem Labs' board has approved the merger of its wholly-owned subsidiary, Adroit Biomed, with itself. This move aims to integrate business operations, enhance scale, optimize costs, and simplify the corporate structure. Adroit Biomed, engaged in pharmaceuticals and nutraceuticals trading, reported ₹59.68 Cr revenue and ₹7.57 Cr net worth in FY25....
Alkem Laboratories' subsidiary, Alkem Medtech Private (AMPL), is merging with its own wholly-owned subsidiary, Alkem Medtech Ortho Private (AMOPL). This move aims to simplify the group structure, optimize operations, reduce costs, enhance efficiency, and expand the combined entity's product portfolio. Financials (as of March 2025): AMOPL had a paid-up capital...